UBS Group’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11K | Sell |
|
|||||
|
2025
Q1 | $74.4K | Buy |
|
|||||
|
2024
Q4 | $52.7K | Buy |
|
|||||
|
2024
Q3 | $1.8K | Sell |
|
|||||
|
2024
Q2 | $27K | Sell |
|
|||||
|
2024
Q1 | $41.9K | Sell |
|
|||||
|
2023
Q4 | $41.2K | Buy |
|
|||||
|
2023
Q3 | $78K | Buy |
|
|||||
|
2023
Q2 | $27.6K | Sell |
|
|||||
|
2023
Q1 | $63.6K | Sell |
|
|||||
|
2022
Q4 | $97.1K | Buy |
|
|||||
|
2022
Q3 | $6K | Sell |
|
|||||
|
2022
Q2 | $4K | Hold |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $827K | Buy |
|
|||||
|
2021
Q3 | $1.1M | Buy |
|
|||||
|
2021
Q2 | $357K | Sell |
|
|||||
|
2021
Q1 | $1.68M | Buy |
|
|||||
|
2020
Q4 | $11K | Sell |
|
|||||
|
2020
Q3 | $28K | Buy |
|